Having trouble accessing articles? Reset your cache.

ARRY-380: Interim Phase I data

Interim data from 17 evaluable patients with HER2-positive metastatic breast cancer from a dose-escalation Phase

Read the full 151 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE